Recombinant FOLR1 (Mirvetuximab Biosimilar) 抗体
Research Grade
适用: 人
ELISA, WB
宿主: Human
Chimeric
unconjugated
Recombinant Antibody
-
- 抗原
- FOLR1 (Mirvetuximab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
-
Human
- Expression System
- Mammalian cells
-
克隆类型
- Chimeric
-
标记
- This FOLR1 (Mirvetuximab Biosimilar) antibody is un-conjugated
- 应用范围
- ELISA, Western Blotting (WB)
- 原理
- Mirvetuximab Biosimilar - Anti-FOLR1 mAb - Research Grade
- 产品特性
- Antibody Type: IgG1-kappa
- 纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
- 纯度
- > 85%
- 质量等级
- Research Grade
- 亚型
- IgG1 kappa
-
anti-FOLR1 (Mirvetuximab Biosimilar) (Glu239Asp-Mutant), (Met241Leu-Mutant) antibody
Research Grade 适用: 人 ELISA, FACS 宿主: 小鼠 Chimeric unconjugated
-
- 限制
- 仅限研究用
-
- 缓冲液
- PBS buffer PH7.5
- 储存条件
- -80 °C
- 储存方法
- store at -80°C
-
- 抗原
- FOLR1 (Mirvetuximab Biosimilar)
- 物质类
- Biosimilar
- 背景
- Mirvetuximab is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research.
- CAS-编号
- 1453084-36-0
-
You are here:
